Mahidol university
Bangkok, Thailand
NCT Number: NCT01488396
The purpose of this study is to evaluate the efficacy of 0.05% cyclosporin ophthalmic emulsion (Restasis) in patients with Stevens-Johnson syndrome that have dry eyes by subjective symptoms and signs.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Bangkok, Thailand
Stevens-Johnson syndrome patients in chronic stage who have dry eys symptoms and signs will be treated with 0.05%cyclosporin ophthalmic emulsion(Restasis)twice a day for 6 months, compare results at 0,2,4,6 months include dry eye symptoms, corneal staining (Fluorescein, Rose Bengal), Schirmer I,FCT and impression cytology
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
2.1.Rose Bengal score is not less than 4 2.2.Fluorescein stain at cornea 2.3.Impression cytology is consistent to dry eye
Exclusion criteria
use twice daily for 6 months
Other names: cyclosporin A
Time frame: 0, 2, 4, 6 months
Time frame: 0, 6 months
Time frame: 0, 6 month
Time frame: 0, 2, 4, 6 months
Staining with fluorescein and rose bengal
Time frame: 0, 2. 4. 6 months
Mahidol University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02987257
Chemically-Induced Disorders, Dermatitis
Phoenix, Arizona, United States
View Trial DetailsNCT06474078
Chemically-Induced Disorders, Dermatitis
Taoyuan, Taiwan
View Trial DetailsNCT02945176
Aniridia, Burns
Cologne, Germany
View Trial DetailsNCT06263140
Avitaminosis, Chemically-Induced Disorders
Bangkok, Thailand
View Trial Details